What is BioHarvest Sciences?
BioHarvest Sciences operates at the intersection of biotechnology and industrial manufacturing, leveraging a sophisticated plant cell technology platform. By focusing on the production of plant metabolites at an industrial scale, the company addresses critical supply chain inefficiencies and quality control challenges inherent in traditional botanical extraction methods. This innovative approach positions BioHarvest Sciences as a disruptive force in the nutraceutical and pharmaceutical ingredient markets, providing a sustainable and consistent alternative to conventional cultivation. The company's ability to synthesize complex compounds without the need for agricultural land or seasonal variability represents a significant competitive advantage in the current bio-manufacturing landscape.
How much funding has BioHarvest Sciences raised?
BioHarvest Sciences has raised a total of $796K across 2 funding rounds:
Stock/Share Issuance
$402K
Other Financing Round
$394K
Stock/Share Issuance (2025): $402K, investors not publicly disclosed
Other Financing Round (2025): $394K, investors not publicly disclosed
Key Investors in BioHarvest Sciences
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for BioHarvest Sciences?
Following this major strategic investment, BioHarvest Sciences is well-positioned to accelerate its commercialization efforts and expand its production capacity. The capital will likely be deployed toward scaling manufacturing infrastructure and deepening research and development initiatives to broaden the portfolio of plant-derived metabolites. As the company transitions into a more mature phase of enterprise-level operations, the focus will shift toward optimizing unit economics and securing strategic partnerships with global distributors. Investors will be monitoring the firm's ability to maintain its technological lead while navigating the regulatory complexities associated with large-scale bio-production, ensuring that the recent influx of capital translates into sustainable revenue growth and market share expansion.
See full BioHarvest Sciences company page
